Ping Chen
About Ping Chen
Ping Chen is a Project Officer at the National Institute of Allergy and Infectious Diseases (NIAID), where he has worked since 2006. He has extensive experience in managing R&D contracts for biodefense and infectious diseases, and previously served as Director at NIAID and Sequella, Inc.
Work at National Institutes of Health
Ping Chen currently serves as a Project Officer at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). He has held this position since 2006, accumulating 18 years of experience in this role. His work focuses on managing research and development contracts, particularly in the area of therapeutic countermeasures for biodefense and emerging infectious diseases. Chen has developed skills in strategic development and global collaboration during his tenure at NIAID.
Previous Role as Director at NIAID
From 2013 to 2019, Ping Chen served as the Director at the NIAID China office, where he spent six years promoting bilateral research collaborations in infectious, allergic, and immunological diseases. His leadership in this role contributed to enhancing international cooperation in critical health research areas. Prior to this, he worked as a Principal Investigator at the Walter Reed Army Institute of Research from 1999 to 2001.
Educational Background in Chemistry and Biochemistry
Ping Chen earned a Bachelor of Arts degree in Chemistry from Berea College, where he studied from 1984 to 1988. He later pursued advanced studies at The Johns Hopkins University, obtaining a PhD in Biochemistry between 1988 and 1995. This educational background has provided him with a strong foundation in the scientific principles necessary for his career in research and development.
Experience at Sequella, Inc.
Before joining NIAID, Ping Chen worked at Sequella, Inc. as the Director of Microbiology from 2001 to 2006. In this role, he was involved in microbiological research and development, contributing to the advancement of therapeutic agents. His experience at Sequella further enhanced his expertise in the field of infectious diseases.
Expertise in R&D Contract Management
Ping Chen has specialized expertise in managing research and development contracts, particularly for the development of therapeutic countermeasures against biodefense threats and emerging infectious diseases. He has provided technical oversight for various therapeutic agents, including those with oral, injectable, and inhaled formulations. His extensive knowledge in anti-infective development and familiarity with U.S. government R&D contracting and project management are significant aspects of his professional profile.